PBS Biotech is a leading provider of innovative single-use bioreactor systems tailored for the cultivation of shear-sensitive cell types in cell therapy development. Our scalable, cost-effective solutions span from benchtop R&D to large-scale cGMP manufacturing, complemented by expert process development services to accelerate commercialization. PBS Biotech's focus on USP Class VI plastics and 3D cell culture technologies sets them apart in the industry.
Shape the Future of Cell Therapy — From Lab to Real-World Impact at PBS Biotech, where we are transforming how advanced therapies are developed and scaled.
PBS Biotech is a leading provider of innovative single-use bioreactor systems tailored for the cultivation of shear-sensitive cell types in cell therapy development. Our scalable, cost-effective solutions span from benchtop R&D to large-scale cGMP manufacturing, complemented by expert process development services to accelerate commercialization. PBS Biotech's focus on USP Class VI plastics and 3D cell culture technologies sets them apart in the industry.
MacroGenics